Brainstorm Cell Therapeutics Inc.
BCLI · OTC
Bulios Fair Price
$1.12
28.7% upside
Trenutna cena
$0.87
Po podatkih Bulios Fair Price je delnica BCLI trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology company focused on researching and developing therapies for neurological disorders. The company specializes in utilizing its proprietary technologies and methods for treating and improving the quality of life for patients suffering from neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS). Brainstorm Cell Therapeutics is developing innovative cell-based therapeutic approaches that offer hope for improving the health of those grappling with these serious diseases. Investors interested in the biotechnology sector and medical research may find the shares of Brainstorm Cell Therapeutics Inc. (BCLI) to be an intriguing investment opportunity.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Chaim Lebovits
Employees
19
Headquarters
New York City
Prihajajoči dogodki
Earnings
Upcoming earnings report